Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Invested Capital (2017 - 2025)

Amicus Therapeutics filings provide 9 years of Return on Invested Capital readings, the most recent being 0.07% for Q4 2025.

  • On a quarterly basis, Return on Invested Capital fell 7.0% to 0.07% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.07%, a 7.0% decrease, with the full-year FY2025 number at 0.07%, down 8.0% from a year prior.
  • Return on Invested Capital hit 0.07% in Q4 2025 for Amicus Therapeutics, down from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q1 2025 to a low of 0.07% in Q4 2025.
  • Median Return on Invested Capital over the past 5 years was 0.0% (2021), compared with a mean of 0.01%.
  • The widest YoY moves for Return on Invested Capital: up 1bps in 2025, down -7bps in 2025.
  • Amicus Therapeutics' Return on Invested Capital stood at 0.0% in 2021, then tumbled by -36bps to 0.0% in 2022, then surged by 64bps to 0.0% in 2023, then soared by 158bps to 0.0% in 2024, then plummeted by -8671bps to 0.07% in 2025.
  • The last three reported values for Return on Invested Capital were 0.07% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.